Novartis
The role oversees the drug surveillance program, ensuring compliance with pharmacovigilance regulations, driving safety signal detection, and supporting clinical development teams. It includes leadership of safety operations, audit readiness, and continuous process improvement across global PV activities.
Headquarters
Basel, Basel-Stadt, Switzerland
Company Size
10001+ employees
Founded
1996
Novartis is an innovative medicines company that pursues scientific breakthroughs to improve and extend people's lives. The company develops and delivers medicines across therapeutic areas including cardiovascular, immunology, neuroscience, and oncology, with its treatments reaching 296 million patients worldwide. With more than 250 years of heritage and 30 years as Novartis, the company works to turn innovations into medicines that redefine the future for patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novartis.
Novartis didn’t post a salary, so this is our estimate from similar listings.
Associate Director, Pharmacovigilance Scientist
Tango Therapeutics
Principal Scientist of Safety Surveillance
Revolution Medicines
Director, Drug Safety & Pharmacovigilance Scientist
Dyne Therapeutics
Director, Drug Safety & Pharmacovigilance
Xencor
Pharmacovigilance Signal Detection Lead
Med Communications
Senior Director, Patient Safety & Pharmacovigilance
Latigobio